| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |